ArticleBMC cancer2019

Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.

Daniel D'Almeida Preto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.